Question 1

What is the catalog number for KRT8P28 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for KRT8P28 CRISPR Knock Out 293T Cell Line (Human) is 26077141.

Question 2

What sizes are available for KRT8P28 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

KRT8P28 CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is KRT8P28 CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

KRT8P28 CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 5

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

KRT8P28 CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD3e (B-B12), CF740 conjugate, 0.1mg/mL

ETS1 / (Marker of Tumor Metastasis) (ETS1/1282), CF647 conjugate, 0.1mg/mL

HER-2 / c-erbB-2 / neu / CD340 (ERBB2/3093), CF740 conjugate, 0.1mg/mL

PCNA (PCNA/694), CF647 conjugate, 0.1mg/mL

Thyroid Stimulating Hormone, beta (TSH beta) (Pituitary Marker) (TSHb/1317), CF740 conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF405S conjugate, 0.1mg/mL